Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 300.000 - Reportable Diseases, Surveillance, and Isolation and Quarantine Requirements › Section 300.170 - Laboratory Findings Indicative of Infectious Disease Reportable Directly to the Department by Laboratories

Current through Register 1525, July 5, 2024
In addition to the requirements of
				105 CMR
				300.100,
				300.171,
				300.180(A)
				and (C), all laboratories, including those
				outside of Massachusetts performing examinations on any specimens derived from
				Massachusetts residents that yield evidence of infection due to the organisms
				listed below, shall report such evidence of infection, including results
				identified through sequencing methods as specified by the Department, directly
				to the Department through secure electronic laboratory reporting mechanisms, or
				other method, as defined by the Department, within 24 hours. A laboratory
				contact must be included with each report in addition to the test results,
				source of specimen, date of specimen collection, case's full name, date of
				birth, sex, race and ethnicity, address, telephone number, and name of the
				ordering health care provider. Where specified, additional demographic data,
				clinical data, or epidemiological data may be required. Upon receipt of a
				laboratory report, the Department shall notify the local board of health in the
				town in which the case resides within 24 hours
via
the MAVEN
				surveillance and case management system.
Anaplasma
sp.
Arborviruses including, but not limited to, chikungunya virus,
				eastern equine encephalitis virus, dengue fever virus, Jamestown Canyon virus,
				West Nile virus, yellow fever virus, and Zika virus
Babesia
sp.
Bacillus anthracis
Bordetella bronchiseptica
Bordetella holmseii
Bordetella parapertussis
Bordetella pertussis
Borrelia burgdorferi
Borrelia miyamotoi
Brucella
sp.
Burkholderia mallei
Burkholderia pseudomallei
Campylobacter sp.
Chlamydophila psittaci
Clostridium botulinum
Clostridium difficile
Clostridium perfringens
Clostridium tetani
Corynebacterium diphtheriae
Coxiella burnetii
Cryptosporidium
sp.
Cyclospora cayetanensis
Ehrlichia
sp.
Entamoeba histolytica
Enteroviruses
Escherichia coli
O157:H7
Francisella tularensis
Giardia
sp.
Group A streptococcus, from a usually sterile site
Group B streptococcus, from a usually sterile site in children
				younger than one year old
Haemophilus influenzae
, from a
				usually sterile site
Hantavirus
Hemorrhagic fever viruses including, but not limited to, Ebola
				virus, Marburg virus, and other filoviruses, arenaviruses, bunyaviruses and
				flaviviruses
Hepatitis A virus
Hepatitis B virus
Hepatitis C virus
Hepatitis D virus
Hepatitis E virus
Evidence of human prion disease
Influenza A and B viruses
Legionella
sp.
Listeria
sp.
Lymphocytic choriomeningitis virus
Measles virus
Mumps virus
Mycobacterium leprae
Mycobacterium tuberculosis, M. africanum, M.
				bovis
Neisseria meningitidis
, from a usually sterile
				site
Noroviruses
Novel or unusual coronaviruses causing severe disease
Novel influenza A viruses
Plasmodium sp. including P. falciparum, P. malariae, P.
				ovale. P. vivax
Poliovirus
Powassan virus
Pox viruses including, but not limited to, variola, vaccinia,
				and other orthopox and parapox viruses, but excluding molluscum contagiosum
				viruses
Rabies virus
Rickettsia akari
Rickettsia prowazekii
Rickettsia rickettsii
Rubella virus
Salmonella
sp.
SARS-CoV-2
Shiga toxin-producing organisms
Shigella
sp.
Simian herpes virus
Streptococcus pneumoniae
, from a usually
				sterile site in individuals younger than 18 years old
Trichinella spiralis
Laboratory evidence of tuberculosis infection
Varicella
zoster virus
Vibrio
sp.
Yersinia pestis
Yersinia
sp.
Evidence of infection due to the organisms listed below shall
				also be reported directly to the Department through secure electronic
				laboratory reporting mechanisms, or other method, as defined by the Department,
				within 24 hours. A laboratory contact must be included with each report in
				addition to the test results, source of specimen, date of specimen collection,
				case's full name, date of birth, sex, race and ethnicity, address, telephone
				number, and name of the ordering health care provider. Where specified,
				additional demographic data, clinical data, or epidemiological data may be
				required.
Chlamydia trachomatis
Haemophilus ducreyi
Herpes simplex virus, neonatal infection (in child younger than
				60 days old)
Human immunodeficiency virus (HIV)
Klebsiella granulomatis
Neisseria gonorrhoeae
Treponema pallidum